Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/78667
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nikpour, M. | - |
dc.contributor.author | Stevens, W. | - |
dc.contributor.author | Proudman, S. | - |
dc.contributor.author | Buchbinder, R. | - |
dc.contributor.author | Prior, D. | - |
dc.contributor.author | Zochling, J. | - |
dc.contributor.author | Williams, T. | - |
dc.contributor.author | Gabbay, E. | - |
dc.contributor.author | Nandurkar, H. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Internal Medicine Journal, 2013; 43(5):599-603 | - |
dc.identifier.issn | 1444-0903 | - |
dc.identifier.issn | 1445-5994 | - |
dc.identifier.uri | http://hdl.handle.net/2440/78667 | - |
dc.description.abstract | Pulmonary arterial hypertension (PAH) is a major cause of mortality in scleroderma and despite ‘advanced’ therapies confers a median survival of less than 5 years. Anticoagulation in systemic sclerosis-related PAH (SSc-PAH) is currently one of the most contentious issues in the management of patients with connective tissue disease. While some studies have shown a survival benefit with warfarin therapy in this disease, others have not. Accordingly, a state of clinical equipoise exists in relation to anticoagulation in SSc-PAH. With an over fivefold reduction in mortality demonstrated in some observational studies, the issue of anticoagulation in SSc-PAH demands resolution through a well-designed randomised controlled trial. | - |
dc.description.statementofresponsibility | M. Nikpour, W. Stevens, S. M. Proudman, R. Buchbinder, D. Prior, J. Zochling, T. Williams, E. Gabbay and H. Nandurkar | - |
dc.language.iso | en | - |
dc.publisher | Blackwell Publishing Asia | - |
dc.rights | © 2013 The Authors | - |
dc.source.uri | http://dx.doi.org/10.1111/imj.12111 | - |
dc.subject | scleroderma | - |
dc.subject | systemic sclerosis | - |
dc.subject | pulmonary arterial hypertension | - |
dc.subject | anticoagulation | - |
dc.subject | randomised controlled trial | - |
dc.title | Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/imj.12111 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Proudman, S. [0000-0002-3046-9884] | - |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.